BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37382186)

  • 1. Parents' expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial.
    McGill BC; Wakefield CE; Tucker KM; Daly RA; Donoghoe MW; Vetsch J; Warby M; Fuentes-Bolanos NA; Barlow-Stewart K; Kirk J; Courtney E; O'Brien TA; Marshall GM; Pinese M; Cowley MJ; Tyrrell V; Deyell RJ; Ziegler DS; Hetherington K
    Cancer; 2023 Nov; 129(22):3620-3632. PubMed ID: 37382186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing Pandora's Box: Familial Expectations around the Return of (Future) Germline Results.
    Johnson LM; Mandrell BN; Li C; Lu Z; Gattuso J; Harrison LW; Mori M; Ouma AA; Pritchard M; Sharp KMH; Nichols KE
    AJOB Empir Bioeth; 2022; 13(3):152-165. PubMed ID: 35471132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parents of a child with epilepsy: Views and expectations on receiving genetic results from Whole Genome Sequencing.
    Jaitovich Groisman I; Hurlimann T; Godard B
    Epilepsy Behav; 2019 Jan; 90():178-190. PubMed ID: 30583270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parents' and adolescents' perspectives and understanding of information about childhood cancer precision medicine.
    Gereis JM; Hetherington K; Robertson EG; Daly R; Donoghoe MW; Ziegler DS; Marshall GM; Lau LMS; Marron JM; Wakefield CE
    Cancer; 2023 Nov; 129(22):3645-3655. PubMed ID: 37376781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parent Quality of Life After Disclosure of Pediatric Oncology Germline Sequencing Results.
    Howard Sharp KM; Li C; Lu Z; Clark ME; Jurbergs N; Ouma A; Harrison L; Gerhardt E; Taylor L; Hamilton KV; McGee RB; Nuccio R; Hines-Dowell S; Gattuso JS; Pritchard M; Mandrell BN; Tercyak KP; Nichols KE; Johnson LM
    JCO Precis Oncol; 2023 Sep; 7():e2300159. PubMed ID: 37944075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers.
    Jahn A; Rump A; Widmann TJ; Heining C; Horak P; Hutter B; Paramasivam N; Uhrig S; Gieldon L; Drukewitz S; Kübler A; Bermudez M; Hackmann K; Porrmann J; Wagner J; Arlt M; Franke M; Fischer J; Kowalzyk Z; William D; Weth V; Oster S; Fröhlich M; Hüllein J; Valle González C; Kreutzfeldt S; Mock A; Heilig CE; Lipka DB; Möhrmann L; Hanf D; Oleś M; Teleanu V; Allgäuer M; Ruhnke L; Kutz O; Knurr A; Laßmann A; Endris V; Neumann O; Penzel R; Beck K; Richter D; Winter U; Wolf S; Pfütze K; Geörg C; Meißburger B; Buchhalter I; Augustin M; Aulitzky WE; Hohenberger P; Kroiss M; Schirmacher P; Schlenk RF; Keilholz U; Klauschen F; Folprecht G; Bauer S; Siveke JT; Brandts CH; Kindler T; Boerries M; Illert AL; von Bubnoff N; Jost PJ; Metzeler KH; Bitzer M; Schulze-Osthoff K; von Kalle C; Brors B; Stenzinger A; Weichert W; Hübschmann D; Fröhling S; Glimm H; Schröck E; Klink B
    Ann Oncol; 2022 Nov; 33(11):1186-1199. PubMed ID: 35988656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
    Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
    J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology.
    Jacobs MF; Goldman JW; Austin S; Koeppe ES; Murad AM; Koschmann CJ; Chinnaiyan AM; Mody RJ
    JCO Precis Oncol; 2024 Mar; 8():e2300539. PubMed ID: 38484211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoning in on parents' needs: understanding parents' perspectives in order to provide person-centered care.
    Jones JE; Kessler-Jones A; Thompson MK; Young K; Anderson AJ; Strand DM
    Epilepsy Behav; 2014 Aug; 37():191-7. PubMed ID: 25050778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index and childhood symptoms of depression, anxiety, and attention-deficit hyperactivity disorder: A within-family Mendelian randomization study.
    Hughes AM; Sanderson E; Morris T; Ayorech Z; Tesli M; Ask H; Reichborn-Kjennerud T; Andreassen OA; Magnus P; Helgeland Ø; Johansson S; Njølstad P; Davey Smith G; Havdahl A; Howe LD; Davies NM
    Elife; 2022 Dec; 11():. PubMed ID: 36537070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parental Understanding of Their Child's Germline Genomic Testing: Intent of Disclosure to Their Child and Family.
    Mandrell BN; Blake AK; Sharp KMH; Gattuso JS; McGee RB; Harrison L; Ouma A; Caples M; Johnson LM; Nichols KE
    J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parental experiences of educational supports offered during their child's cancer treatment.
    Huang HM; Yeh TC; Liu HC; Lee TY
    Child Care Health Dev; 2022 May; 48(3):486-493. PubMed ID: 34905229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm?
    Anderson JA; Meyn MS; Shuman C; Zlotnik Shaul R; Mantella LE; Szego MJ; Bowdin S; Monfared N; Hayeems RZ
    J Med Ethics; 2017 Aug; 43(8):535-539. PubMed ID: 27888232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.
    Marron JM; DuBois SG; Glade Bender J; Kim A; Crompton BD; Meyer SC; Janeway KA; Mack JW
    Pediatr Blood Cancer; 2016 Nov; 63(11):1974-82. PubMed ID: 27429135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. After genomic testing results: Parents' long-term views.
    Liang NSY; Adam S; Elliott AM; Siemens A; du Souich C; ; ; Friedman JM; Birch P
    J Genet Couns; 2022 Feb; 31(1):82-95. PubMed ID: 34165210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine.
    You YN; Borras E; Chang K; Price BA; Mork M; Chang GJ; Rodriguez-Bigas MA; Bednarski BK; Meric-Bernstam F; Vilar E
    Dis Colon Rectum; 2019 Apr; 62(4):429-437. PubMed ID: 30730459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parents', Health Care Professionals', and Scientists' Experiences of a Precision Medicine Pilot Trial for Patients With High-Risk Childhood Cancer: A Qualitative Study.
    Vetsch J; Wakefield CE; Duve E; McGill BC; Warby M; Tucker KM; Malkin D; Lau L; Ziegler DS
    JCO Precis Oncol; 2019 Dec; 3():1-11. PubMed ID: 35100729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
    Rasnic R; Brandes N; Zuk O; Linial M
    BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
    Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
    Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system.
    Higashigawa S; Matsubayashi H; Kiyozumi Y; Kado N; Nishimura S; Oishi T; Sugino T; Fushiki K; Shirasu H; Yasui H; Mamesaya N; Fukuzaki N; Kunitomo K; Horiuchi Y; Kenmotsu H; Serizawa M
    Jpn J Clin Oncol; 2022 May; 52(6):599-608. PubMed ID: 35411369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.